نتایج جستجو برای: breast cancer recurrence prediction

تعداد نتایج: 1281767  

Journal: :Archives of surgery 2006
David E Konkin Scott Tyldesley Hagen Kennecke Caroline H Speers Ivo A Olivotto Noelle Davis

HYPOTHESIS Management strategies affect the outcome of axillary recurrence in breast cancer. DESIGN Population-based analysis. SETTING Cancer agency breast cancer database. PATIENTS Two hundred twenty women diagnosed with stage 0 through III breast cancer between 1989 and 2003 who subsequently developed an isolated axillary relapse. MAIN OUTCOME MEASURES Overall survival rate and diseas...

Journal: :Cancer research 2013
Kristen N Stevens Celine M Vachon Fergus J Couch

Triple-negative breast cancers (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and HER-2 expression, account for 12% to 24% of all breast cancers. TNBC is associated with early recurrence of disease and poor outcome. Germline mutations in the BRCA1 and BRCA2 breast cancer susceptibility genes have been associated with up to 15% of TNBC, and TNBC accounts for 70% of b...

2016
Shaw-Ji Chen Chun-Hung Chang Kuang-Chi Chen Chieh-Yu Liu

The aim of the study was to investigate the association between depressive disorders and risk of tumor recurrence in patients with breast cancer after curative surgery.A nationwide cohort study between January 2001 and December 2007 was conducted. Data were taken from the Taiwan National Health Insurance Research Database. Among 30,659 newly diagnosed breast cancer patients, we identified 1147 ...

Journal: :Breast cancer 2014
Wakako Tsuji Satoshi Teramukai Masaya Ueno Masakazu Toi Takashi Inamoto

INTRODUCTION Previous studies have shown that primary breast cancer patients with estrogen receptor (ER)-positive status have better outcomes in terms of both overall survival and disease-free intervals (DFI). However, 25.2 % of our ER-positive patients experienced recurrence. This study aimed to define factors potentially predicting survival after first recurrence in surgically treated patient...

Journal: :Cancer research 2007
K Eric Paulson Kimberly Rieger-Christ Michael A McDevitt Charlotte Kuperwasser Jiyoung Kim Vincent E Unanue Xiaowei Zhang Maowen Hu Robin Ruthazer Stephen P Berasi Chun-Yin Huang Dilip Giri Seth Kaufman John M Dugan Joanne Blum Georges Netto David E Wazer Ian C Summerhayes Amy S Yee

Invasive breast cancer has a high risk of recurrence to incurable disease and needs improved prognostic and therapeutic tools. Our work combines clinical and molecular analyses to show that the transcriptional repressor HBP1 may be a new target for invasive breast cancer. Previous work indicated that HBP1 regulated proliferation and senescence and inhibited Wnt signaling. Two of these functions...

انصاری نژاد, نفیسه, رمیم, طیب, عباسی, بهاره, فرداد, فرشید, نصیری‌پور, سمیه,

Stable molecular changes during cell division without any change in the sequence of DNA molecules is known as epigenetic. Molecular mechanisms involved in this process, including histone modifications, methylation of DNA, protein complex and RNA antisense. Cancer genome changes happen through a combination of DNA hypermethylation, long-term epigenetic silencing with heterozygosis loss and genom...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016
Reena S Cecchini Sandra M Swain Joseph P Costantino Priya Rastogi Jong-Hyeon Jeong Stewart J Anderson Gong Tang Charles E Geyer Barry C Lembersky Edward H Romond Alexander H G Paterson Norman Wolmark

BACKGROUND Body mass index (BMI) has been associated with breast cancer outcomes. However, few studies used clinical trial settings where treatments and outcomes are consistently evaluated and documented. There are also limited data assessing how patient/disease characteristics and treatment may alter the BMI-breast cancer association. METHODS We evaluated 15,538 breast cancer participants fr...

Journal: :Epidemiology 2016
Deirdre P Cronin-Fenton Uffe Heide-Jørgensen Thomas P Ahern Timothy L Lash Peer Christiansen Bent Ejlertsen Henrik T Sørensen

BACKGROUND Aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast cancer recurrence. METHODS We identified incident stage I-III Danish breast cancer patients in the Danish Breast Cancer Cooperative Group registry,...

Journal: :The Lancet 2005
M Clarke R Collins S Darby C Davies P Elphinstone V Evans J Godwin R Gray C Hicks S James E MacKinnon P McGale T McHugh R Peto C Taylor Y Wang

BACKGROUND In early breast cancer, variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer mortality. To examine this relationship, collaborative meta-analyses were undertaken, based on individual patient data, of the relevant randomised trials that began by 1995. METHODS Information was available on 42,000 women in...

2015
Guinian Wang Longzi Wang Sijing Sun Juan Wu Qinglu Wang

BACKGROUND Breast cancer is the most common type of cancer in females. Aberrant expression of microRNA-21 (miR-21) has previously been reported in breast cancer tissue. The aim of this study was to investigate expression levels of serum miR-21 in breast cancer patients and evaluate its prognostic value in Chinese females. METHODS Real-time quantitative (RQ)-PCR was used to analyze miR-21 expr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید